Theseus Pharmaceuticals Buy Hold or Sell Recommendation
| THRXDelisted Stock | USD 3.71 0.14 3.92% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Theseus Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Theseus Pharmaceuticals given historical horizon and risk tolerance towards Theseus Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Theseus Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. In addition, we conduct extensive research on individual companies such as Theseus and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Theseus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Theseus |
Execute Theseus Pharmaceuticals Buy or Sell Advice
The Theseus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Theseus Pharmaceuticals. Macroaxis does not own or have any residual interests in Theseus Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Theseus Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Theseus Pharmaceuticals Trading Alerts and Improvement Suggestions
| Theseus Pharmaceuticals is not yet fully synchronised with the market data | |
| Theseus Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (56.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Theseus Pharmaceuticals currently holds about 212.43 M in cash with (49.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 93.0% of the company shares are owned by institutional investors |
Theseus Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Theseus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Theseus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Theseus Pharmaceuticals Returns Distribution Density
The distribution of Theseus Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Theseus Pharmaceuticals' future price movements. The chart of the probability distribution of Theseus Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Theseus Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Theseus Pharmaceuticals returns is essential to provide solid investment advice for Theseus Pharmaceuticals.
| Mean Return | -0.54 | Value At Risk | -8.57 | Potential Upside | 11.75 | Standard Deviation | 10.73 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Theseus Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Exercise or conversion by William Shakespeare of 251084 shares of Theseus Pharmaceuticals subject to Rule 16b-3 [view details]
Theseus Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Theseus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Theseus Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Theseus Pharmaceuticals? Buying financial instruments such as Theseus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Theseus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |